Beneficial effects of creatine, CoQ10, and lipoic acid in mitochondrial disorders - Wikidata - wikimedia - TriplyDB

Beneficial effects of creatine, CoQ10, and lipoic acid in mitochondrial disorders

Beneficial effects of creatine, CoQ10, and lipoic acid in mitochondrial disorders

http://www.wikidata.org/entity/Q28271871

about

Mitochondrial modulators for bipolar disorder: A pathophysiologically informed paradigm for new drug development Treatment for mitochondrial disorders Creatine for treating muscle disorders Creatine for treating muscle disorders The creatine kinase system and pleiotropic effects of creatine Mitochondrial disorders in children: toward development of small-molecule treatment strategies Genetics of ischaemic stroke in young adults A review on mitochondrial restorative mechanism of antioxidants in Alzheimer's disease and other neurological conditions Mitochondrial DNA depletion syndromes: review and updates of genetic basis, manifestations, and therapeutic options Mitochondrial disorders: challenges in diagnosis & treatment Supplementation with α-lipoic acid, CoQ10, and vitamin E augments running performance and mitochondrial function in female mice Primary Mitochondrial Disease and Secondary Mitochondrial Dysfunction: Importance of Distinction for Diagnosis and Treatment Beneficial effects of a Q-ter based nutritional mixture on functional performance, mitochondrial function, and oxidative stress in rats Coenzyme Q10 and Neurological Diseases.Creatine monohydrate and conjugated linoleic acid improve strength and body composition following resistance exercise in older adults.Mitochondrial DNA sequence associations with dementia and amyloid-β in elderly African Americans Young-onset dementia Mitochondrial disorders and the eye.Treatment of mitochondrial disorders.Therapeutic use of creatine in brain or heart ischemia: available data and future perspectives.Mitochondrial optic neuropathies - disease mechanisms and therapeutic strategies.The neuro-ophthalmology of mitochondrial disease Effects of coenzyme Q10 on the ratio of TH1/TH2 in experimental autoimmune encephalomyelitis model of multiple sclerosis in C57BL/6.Genetic stroke syndromes Antioxidants halt axonal degeneration in a mouse model of X-adrenoleukodystrophy.Current experience in testing mitochondrial nutrients in disorders featuring oxidative stress and mitochondrial dysfunction: rational design of chemoprevention trials.Why are there no proven therapies for genetic mitochondrial diseases?Oxidative damage compromises energy metabolism in the axonal degeneration mouse model of X-adrenoleukodystrophy.Treatment of Leber hereditary optic neuropathy Symptoms of somatization as a rapid screening tool for mitochondrial dysfunction in depression.Diagnosis and treatment of mitochondrial myopathies Kearns-Sayre syndrome presenting as isolated growth failure.The elusive magic pill: finding effective therapies for mitochondrial disorders Review of clinical trials for mitochondrial disorders: 1997-2012.Liver disease in mitochondrial disorders.New treatments for mitochondrial disease-no time to drop our standards.Diagnosis and management of mitochondrial disease: a consensus statement from the Mitochondrial Medicine Society.Multiple neurologic, psychiatric, and endocrine complaints in a young woman: a case discussion and review of the clinical features and management of mitochondrial myopathy, encephalopathy, lactic acidosis, and stroke.The Protective Effects of Alpha-Lipoic Acid and Coenzyme Q10 Combination on Ovarian Ischemia-Reperfusion Injury: An Experimental Study How can we treat mitochondrial encephalomyopathies? Approaches to therapy

P2860

Q22241837-D7A611BB-486A-4615-85BA-EF835F6124A7 Q24200432-6DC2C07C-FE03-4F60-85E0-0E4DBBB4C970 Q24202243-4B9E2474-6D76-42C8-96DD-8CC88140E50D Q24236598-33E8994B-1516-4123-B386-1A58FE6393E3 Q24609852-992569EA-FDEB-420E-A313-ED78B54B1462 Q26767327-BD35BB57-9E01-4D0D-8828-065F6ABEF209 Q26775633-4593A5B0-3276-49F3-BACE-B9B669FA40BA Q26781560-2E5E99CF-0FAA-4D35-9819-E361550766D2 Q26865135-01D4456D-B0AD-497E-A925-63B39ABF1421 Q27000484-863C998F-14CC-484A-A313-CF931F4D4B08 Q27329547-9589FEDB-50DE-4069-9F99-EFAD30B98C2C Q28078384-C5F0FE95-F16D-459C-9D2A-A38D5C8443DB Q28473890-4E27214B-72E8-452B-A422-893FE3EE6B50 Q30440307-143B8475-507B-4A8F-A2BF-0026157A9D9F Q33301343-178F1C62-CB64-493B-BCA5-8B60C94193FD Q33603868-372DFFAF-9B6E-46C5-9086-99A15687CA9F Q33660849-E2675054-DD99-4100-8CC9-7F9F913D9BCE Q33702120-1770233D-5CD3-42D8-B8C3-E12C5D429223 Q33794684-9CD5E725-65DB-4AA2-81B3-8AC8A0BA1552 Q34089086-660C2653-B6C0-4DC2-B6D8-6268185A17BA Q34152110-8EF7E1DE-5D30-4EAC-88BD-65483A8A0128 Q34338783-35606805-AFFA-4547-AF48-03B5A06A66C7 Q34475830-471B310C-A645-4065-A990-831AE99A8062 Q34522989-C8D572EB-1362-403C-94C1-AB9035F51BAC Q34631169-596D7464-76BA-4C3B-81E0-5761CA8C6E6C Q34685307-230349B8-3A0A-4A2E-B43C-055E67E5D99F Q35162928-1DF369AE-6F23-4AA7-9B67-12D49D59C75D Q35193956-F97BF27E-C7B6-4A25-8BC7-394293D8127B Q35452117-CF0D5DD6-255B-4C1A-9292-42C40B384DE8 Q36515986-C57E2D80-613A-439C-810B-8FCAD6701E51 Q36634939-4C44F1AF-7B3B-4DA4-9B0F-5BBCC4A38CA3 Q36704799-27926BFD-213D-4144-A2B0-118279F7A88D Q36762813-9499B811-04FE-413D-B8A5-F14A2CF1A82D Q36762846-A5364BC6-559F-4CE8-BE59-7E479F173BEA Q36903648-414FDE77-81A2-4CB7-8777-AF857CA44258 Q37140299-C432A213-CFA2-4FDC-B81D-9010A5AE6E9B Q37210464-97CCC0FC-1BB8-4107-9559-36DBDD07BA17 Q37211810-8B553A06-177B-41AF-BCF1-8DEE895448CF Q37212575-4B8B0FD2-C5CC-4EF5-B0A5-DC993EFF5ABF Q37329530-28CE0835-1090-4888-AFA3-33BCCF4EB474

P2860

Beneficial effects of creatine, CoQ10, and lipoic acid in mitochondrial disorders

http://www.wikidata.org/entity/Q28271871

description

2007 nî lūn-bûn

@nan

2007 թուականի Փետրուարին հրատարակուած գիտական յօդուած

@hyw

2007 թվականի փետրվարին հրատարակված գիտական հոդված

@hy

2007年の論文

@ja

2007年論文

@yue

2007年論文

@zh-hant

2007年論文

@zh-hk

2007年論文

@zh-mo

2007年論文

@zh-tw

2007年论文

@wuu

name

Beneficial effects of creatine, CoQ10, and lipoic acid in mitochondrial disorders

@ast

Beneficial effects of creatine, CoQ10, and lipoic acid in mitochondrial disorders

@en

Beneficial effects of creatine, CoQ10, and lipoic acid in mitochondrial disorders

@nl

type

label

Beneficial effects of creatine, CoQ10, and lipoic acid in mitochondrial disorders

@ast

Beneficial effects of creatine, CoQ10, and lipoic acid in mitochondrial disorders

@en

Beneficial effects of creatine, CoQ10, and lipoic acid in mitochondrial disorders

@nl

prefLabel

Beneficial effects of creatine, CoQ10, and lipoic acid in mitochondrial disorders

@ast

Beneficial effects of creatine, CoQ10, and lipoic acid in mitochondrial disorders

@en

Beneficial effects of creatine, CoQ10, and lipoic acid in mitochondrial disorders

@nl

P1433

Q28271871-28853E7C-C26F-4D37-9C53-198D129711D8

P1476

Q28271871-E05A413D-D19E-4223-8357-DB14133174C9

P2093

Q28271871-1227244D-00EA-4398-A1B4-9DA376F7A9FE

Q28271871-33B49557-1DA9-4AD1-83B1-F3C079ACF060

Q28271871-407027E3-3F3B-4C54-BF18-04A540B49D41

Q28271871-8729EFE3-972B-462A-98C9-6664EC454270

Q28271871-8EE4E039-A33F-4EC2-B302-83286AE0AAD0

Q28271871-A7EDA4C7-E8A6-4428-B1E5-A88E2897DBAD

P2860

Q28271871-20D6D720-E352-4430-9B35-7D19F186A6A4

Q28271871-302CF3A7-2EF2-4120-BE48-CA8EE3615918

Q28271871-56BDE619-47FD-44DF-9300-B33257543F07

Q28271871-5C9198E0-B45F-441C-8654-F0A322D1434F

Q28271871-C62ED617-32BB-4D70-84AF-883E27120968

Q28271871-CE0E32DE-2B9F-4A5C-85BD-0043F181901D

Q28271871-DCD325AE-8110-4254-A470-EDBC2E6C2893

P304

Q28271871-25810392-1474-4E5A-899B-B51DEED60084

P31

Q28271871-8D9B3E5B-8E68-433F-B19B-63FB05F13B91

P3181

Q28271871-1DAD4D94-8FE3-4FB9-82A1-26861D916FB7

P356

Q28271871-94169712-E830-48FD-B009-5F37AE04C8A9

P407

Q28271871-385B3D09-60F7-4FDF-9577-7534F4F8CA87

P433

Q28271871-A264D5FF-9520-4986-898B-7FBA43AB9F96

P478

Q28271871-F16F0AE6-CCDC-4950-BA9B-FCEE0264C4D0

P577

Q28271871-50BF7FE5-143E-4F60-91F2-66F7A3F79B7F

P698

Q28271871-F161A5B4-012B-42C3-9D78-DE33C202C066

P921

Q28271871-1A983F1F-87D0-4FD2-B01A-78D33A62A51A

P3181

P356

P1433

Muscle and Nerve

P1476

Beneficial effects of creatine, CoQ10, and lipoic acid in mitochondrial disorders

@en

P2093

Douglas J Mahoney

http://www.w3.org/2001/XMLSchema#string

Gianni Parise

http://www.w3.org/2001/XMLSchema#string

Jay R MacDonald

http://www.w3.org/2001/XMLSchema#string

M Christine Rodriguez

http://www.w3.org/2001/XMLSchema#string

M Flint Beal

http://www.w3.org/2001/XMLSchema#string

Mark A Tarnopolsky

http://www.w3.org/2001/XMLSchema#string

P2860

Effect of alpha-lipoic acid combined with creatine monohydrate on human skeletal muscle creatine and phosphagen concentration

Lipoic acid as a potential therapy for chronic diseases associated with oxidative stress.

A placebo-controlled crossover trial of creatine in mitochondrial diseases.

Creatine supplementation enhances isometric strength and body composition improvements following strength exercise training in older adults.

Creatine monohydrate enhances strength and body composition in Duchenne muscular dystrophy.

Creatine monohydrate increases strength in patients with neuromuscular disease.

Elevation of creatine in resting and exercised muscle of normal subjects by creatine supplementation.

P304

235-42

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P3181

4076595

http://www.w3.org/2001/XMLSchema#string

P356

10.1002/MUS.20688

http://www.w3.org/2001/XMLSchema#string

P407

P433

2

http://www.w3.org/2001/XMLSchema#string

P478

35

http://www.w3.org/2001/XMLSchema#string

P577

2007-02-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

17080429

http://www.w3.org/2001/XMLSchema#string

P921